Browse Guides  internal medicine  renal medicine

Acute renal failure

Prevalence
Causes
Clinical features
Investigations
Therapy
Prevention
Prognosis
Therapy

Inotropic agents 
  • norepinephrine c (started if systolic blood pressure < 90 mmHg; 0.5 µg/kg/min with increments of 0.3 - 0.6 µg/kg/min to maintain systolic bp >120/80) 

There is no clear benefit from dopamine a  (low-dose: 1 - 3 µg/kg/min). a

Why?

  • Norepinephrine infusion increases urine output, decreases creatinine levels and increases creatinine clearance in around 80% of patients with septic shock. c
  • Norepinephrine stabilises more patients in hyperdynamic septic shock than dopamine a
  • Dopamine acutely increases urine output and creatinine clearance in patients with oliguria or established acute renal failure. b
  • The effect on requirement for dialysis, or death is unclear. a

Norepinephrine stabilises septic shock better than dopamine

Patient Treatment Comparison Outcome CER RRR
(95% CI)
NNT
(95% CI)
hyperdynamic septic shock a norepinephrine dopamine haemodynamic stabilisation for at least
at 6 hours
31% 200%
(43% to 530%)
2
(1 to 3)
 

Expiry date: July 2003
Levels of Evidence used in grading these guides

Authors   C   Clase , CM   Ball
Reviewer   S   Hsu
CAT Writers   C   Clase , CM   Ball